We present ProteoClade, a Python toolkit that performs taxa-specific peptide assignment, protein infer-16 ence, and quantitation for multi-species proteomics experiments. ProteoClade scales to hundreds of 17 millions of protein sequences, requires minimal computational resources, and is open source, multi-18 platform, and accessible to non-programmers. We demonstrate its utility for processing quantitative 19 proteomic data derived from patient-derived xenografts and its speed and scalability enable a novel de 20 novo proteomic workflow for complex microbiota samples. 21
command line interface, and was demonstrated to annotate peptides orders of magnitude faster than a 39 prior UniProt-based application, Peptide Match 6, 7 . However, the Unipept database is unavailable for the 40 end-user to customize, is restricted to a fixed set of assumed experimental parameters such as protease, 41 cannot be used with custom protein databases such as those generated by sequencing, and lacks capa-42 bility for protein quantitation which limits its utility for analyzing many experimental data sets. Addi-43 tionally, the Unipept database was generated using high performance computing resources which poses 44 a technical challenge as the number of sequences in UniProt grows exponentially 5, 8 . Other tools offering 45 more complete metaproteomic pipelines such as MetaProteomeAnalyzer (MPA) support database gen-46 eration, peptide spectral matching, and taxonomic parsing. However, these tools restrict the user to 47 bundled open-source targeted database search engines which scale poorly when using large reference 48 database sizes such as the entirety of UniProt 9 . MPA also lacks support for post-translational modifica-49 tions and common MS2-based quantitation approaches, limiting its applicability. 50
To overcome these limitations, we developed ProteoClade, an open-source Python library that enables 51 flexible, rapid, and easy taxon-specific quantification for proteomic experiments. ProteoClade utilizes 52 standard taxonomic and protein sequence repositories and is optimized for large databases. Clade is the first tool to 1) enable users to generate and search customizable, in silico digested peptide-54 to-taxa mapped databases that can scale to the entire UniProt database with the optional inclusion of 55 user-specified reference protein sequences; and 2) provide a novel de novo workflow to efficiently an-56 notate peptides sequenced without defining the taxonomic composition a priori. Additionally, Clade allows the user to choose their preferred commercial or open-source search engine, as well as 58 preserves MS1-, MS2-, and spectral count-based quantitation from the experiment to calculate gene-59 level, taxon-specific quantitative results. Together, ProteoClade uniquely enables fast, taxon-specific 60 quantitation of database-targeted multispecies experiments as well de novo searches enhanced by large 61 databases for complex metaproteomic experiments. The ProteoClade software is freely available at http://github.com/HeldLab/ProteoClade . 63
ProteoClade retrieves complete taxonomic lineages from the NCBI, and interfaces directly with the Uni-64 Prot API to download and concatenate reference protein sequence databases based on the organism IDs 65 and database parameters supplied by the user. To assign peptide-spectral matches from mass spectra 66 search engines to both taxon and gene identifiers, ProteoClade creates a SQLite database (ProteoClade 67 Database: PCDB) by digesting reference proteomes in silico with proteolytic parameters that can be cus-68 tomized according to the user's experimental conditions (Fig. S1) . The PCDB addresses scalability issues 69 by storing peptide sequences as hashed integer values which compresses the average peptide storage 70 requirement by 62.8%. ProteoClade leverages multiple CPUs for parallel processing to speed both the 71 PCDB creation and search functions, and indexes the database to quickly assign peptides to taxon-72 specific genes. ProteoClade's implementation is further detailed in the STAR methods. 73
Metaproteomic experiments involving communities of many organisms present substantial computa-74 tional challenges since more sequence information available to aid in the identification and quantitation 75 of the experimental data requires more computational resources. Thus, it is imperative to efficiently 76 store and parse these data for taxonomic assignment and protein quantitation in light of the dramatic 77 increase in the number of organisms with proteomic annotation. We evaluated ProteoClade's scalability 78 by creating a tryptic PCDB from the November 2018 release of UniProt containing 140.2 million protein 79 entries (UniProt PCDB). The resultant database contained 10.7 billion peptides, 5.02 billion of which 80 were unique, from 1,040,460 organisms. PCDB creation, including indexing, took only 11 hours on mod-81 est consumer-grade hardware and resulted in a 515GB file ( Fig. S2a) , demonstrating that ProteoClade 82 enables the use of large, customizable peptide databases. 83
We compared the database indexing and taxonomic annotation features of Unipept, MetaProteomeAn-84 alyzer (MPA), and ProteoClade to highlight ProteoClade's optimizations and improvements over prior taxonomic tools. For peptide database creation and indexing, ProteoClade uses 32-fold less RAM and 6-86 fold less time than Unipept, and > 60-fold less RAM and > 120 fold less time than MPA (Fig. S2a, S2b) . 87
We found that ProteoClade annotates experiments at 8.8x the speed of Unipept and preserves quantita-88 tive information with the ability to sum the peptides' quantitation to the gene level as is common in 89 multispecies experiments, while MPA lacked the ability to annotate peptides outside of database-90 targeted searches ( Fig. S2c) . ProteoClade's technical optimizations enable taxonomic annotation and 91 quantitation of peptides at a speed and scale that exceed previously used tools. 92
To demonstrate ProteoClade's ability to perform integrated, species-specific quantitation of multi-93 species samples, we analyzed publicly available TMT-labeled global proteomics data from Patient-94 derived xenograft (PDX) lines in which six triple-negative breast cancer tumors were each grafted into 95 three mice, but were originally analyzed without considering mouse-specific peptides 10 . PDXs are a bur-96 geoning, mixed-species model of tumor biology 11 in which the stromal microenvironment of tumors, 97 comprised of fibroblasts, immune-related cells, and vasculature, is originally human but is replaced after 98 several passages by murine cells. Thus, species-specific proteomic analysis of PDX data can simultane-99 ously and independently characterize the tumor and the invasive murine stroma to examine how tu-100 mors remodel stromal proteomes in a process known as stromal education 2 . 101
ProteoClade was used to create a customized, concatenated human and mouse UniProtKB/Swiss-Prot 102 database for both peptide-spectral matching with MaxQuant and creation of a PCDB for species-specific 103 taxonomic annotation and filtering ( Fig. 1a ). In addition, ProteoClade's quantitation module flexibly al-104 lows for species-specific summation of TMT reporter ions to each peptide's assigned gene symbol to 105 generate quantitative proteomic maps of the tumor and stromal proteomes. 106
Taxon-specific peptide assignment with a tool such as ProteoClade is important in multi-species samples 107 since peptides with shared amino acid sequences between human and mouse may bias proteomic quan-titation of PDXs. By digesting peptides in silico, we found that 71.1% of genes in the human proteome 109 produce tryptic peptides with sequences identical to their murine homolog, and thus most human and 110 mouse proteins are potentially susceptible to quantitative interference by the presence of the other or-111 ganism. We examined the consequences of normalizing and quantifying the human and mouse compo-112 nents of the data by comparing a naive informatic assumption that only one organism was present to 113 utilizing ProteoClade for species-specific peptide filtering and protein quantification (Fig. 1b) . The rela-114 tive protein abundance varied by more than 1.5-fold for 262 genes in the human-specific data and 891 115 genes in the murine-specific data, highlighting the large bias that the inclusion or exclusion of species-116 shared peptides can have on the quantitation. Overall, genes share a higher proportion of tryptic pep-117 tides have larger differences in gene-level quantitation indicating that taxonomic interference has a sub-118 stantial effect on the resulting data ( Fig. 1b) . 119
ProteoClade greatly facilitated species-specific quantitation of this PDX dataset 10 , identifying 2,326 mu-120 rine proteins in the microenvironment that are significantly altered by patient-derived tumors, the most 121 expansive set of tumor-educated stromal proteins to date. The murine proteins clustered by biological 122 replicate, confirming that tumor-intrinsic factors drive tumors to persistently educate the stromal pro-123 teome as previously observed ( Fig. 1c ) 2 . ANOVA revealed that stromal education by tumors is wide-124 spread, with 77.1% of stromal proteins differentially regulated by the embedded tumors. Differentially-125 regulated stromal proteins combined from this analysis and a prior study (n = 3,015 proteins) were en-126 riched for proteins in the extracellular matrix, cytoskeletal processes, and myeloid-derived immune 127 components which are important contributors to tumor growth and metastasis ( Fig. 1d) 2, 10 . 128
Beyond two-species systems, we examined ProteoClade's applicability to large-scale metaproteomics 129 workflows using the entire UniProt repository, which enables taxonomic annotation to all potential or-130 ganisms in the sample ( Fig. 2a) . One important consideration for metaproteomic analysis is that all se-quence databases are biased by the inclusion and exclusion criteria selected by their curators. 132
Overrepresentation of peptidomes from certain genera and peptide sequence similarity between relat-133 ed organisms can result in misattributing taxon-specific peptides due to errors in mass spectrometry-134 based detection and sequencing. We establish that UniProt has a substantial sequence bias from the 135 perspective of bottom-up proteomics experiments by quantifying the number of peptides contained in 136 the UniProt PCDB for each genus as well as the proportion of peptide sequences that were unique ( Fig.  137   2b) . By mapping all 5.02 billion unique peptides back to their respective genera, we found that taxonom-138 ic redundancy from the inclusion of thousands of bacterial strains results in vast overrepresentation of 139 tryptic peptides from several genera, including Streptomyces, Pseudomonas, and Bacillus. These 140 overrepresented genera are likely to be identified in nearly every genus-specific proteomic analysis re-141 gardless of their presence or absence in the sample, highlighting the importance of user-customization 142 to database generation. We provide a table of these data to help inform when selecting a narrower da-143 tabase scope for certain genera in UniProt may be appropriate (Table S1) . 144
De novo proteomic analysis is advantageous for metaproteomics since it does not require pre-specifying 145 which organisms are present, which is a requirement for the database-targeted MS2 search approaches 146 universally utilized in metaproteomics. ProteoClade integrates with de novo searches since it can taxo-147 nomically annotate and quantify de novo search results in a unique workflow that can identify organisms 148 and proteins without a priori specification, obviating the need for 16s rRNA sequencing or metagenomic 149 assembly for proteomics studies. ProteoClade enables this unique informatic workflow by assigning mil-150 lions of candidate peptide sequences from de novo searched spectra unbiasedly to all possible organ-151 isms, which ProteoClade makes possible without the use of high performance computing resources ( Fig.  152 
S2).
We evaluated using ProteoClade for de novo peptide assignment of a large oral microbiome proteomic 154 data set 3 previously analyzed with a standard database-targeted approaches by coupling the UniProt 155 PCDB with de novo MS2 assignment ( Fig. 2a) 3 . ProteoClade parsed 8.13 million peptide-spectral match 156 candidates to annotate 1.83 million MS/MS scans in 1.94 hours (261 spectra per second), making this 157 time-efficient even when challenged with large data sets and reference databases. We identified genus-158 unique peptides for 39 genera from the oral microbiome in this dataset without prior specification of 159 the bacterial taxa present in the sample, despite the fact that our criteria for identification included ge-160 nus-specificity in the context of more than 72,000 genera compared to the 108 genera present in the 161 Human Oral Microbiome Database used for the original publication ( Fig. 2c) 12 . 162 We next developed an approach to serially check every candidate sequence for each MS2 spectrum until 163 a match in the PCDB was found, and compared these results to an approach which only considers the 164 top scoring candidate for each spectrum. As de novo search engines lack a reference database and do 165 not provide false discovery correction for peptide sequencing, we additionally used ProteoClade to gen-166 erate a reverse 'decoy' sequence PCDB, and annotated the peptide sequence candidates using the pa-167 rameters we chose for our forward search. We then compared the proportion of annotations to the 168 forward database to the reverse database for each genus, which is the same strategy that is used for 169 most targeted database searches, but is novel to de novo searches 13 . The combination of considering 170 multiple candidate amino acid sequences for every spectrum and offsetting false discovery with a decoy 171 database increased the number of identified genus-unique human peptides by 32.6% in the forward 172 PCDB annotations, while we observed no increase in the reverse, decoy PCDB annotations (Fig. 2c) . This 173 demonstrates that ProteoClade can identify more biologically-valid peptide sequences than would oth-174 erwise be offered by upstream de novo search software. For several bacterial genera, including Prevotel-175 la and Lactobacillus, we found an increase in both the forward and reverse PCDB annotations, indicating 176 that while the number of peptide candidate sequences increased, those candidates are likely false posi-tives. By comparing all forward and reverse annotations, we observed a threshold (>7 Δforward-reverse 178 genus specific peptides) above which only genera known to have been identified in the human oral cavi-179 ty are present. We identified human and 14 bacterial genera above this threshold without prior specifi-180 cation, including Streptococcus, which was previously reported as the most abundant genus in the oral 181 microbiome (Fig. 2d) 14 ProteoClade was used to annotate the resultant peptide ("peptides.txt") files by organism and gene 62 symbol. For each of the mouse and human tissue perspectives, data were analyzed two ways: 1) one in 63 which peptides were included assuming only the organism of interest was present, and 2) one in which 64 both organisms were assumed present for data normalization but separated into species-specific data 65 sets. For method 1, ProteoClade filtered peptides into a data set in which the organism of interest only 66 had to be a plausible assignment for each peptide and the other organism was excluded, simulating a 67 targeted proteomics search in which only a single organism's proteome was used as a reference. 68
ProteoClade assigned peptide sequences and summed the MS2 intensities to gene symbols and then 69 data were normalized by taking the relative intensities of each TMT channel compared to the internal 70 reference pool for each TMT-plex used in the experiment, log2-transforming the data, centering the 71 data by each channel's median, and dividing the relative intensities of each channel by the channel's 72 standard deviation. For method 2, ProteoClade assigned peptides to organisms only if the peptide was 73 unique to that organism in the context of the combined human and mouse proteomes. Downstream 74 processing was similar to method 1, but the human and mouse genes quantified using species-unique 75 peptides were separated to yield two distinct data sets after gene assignment and data normalization. 76
Mouse and human data processing approaches were compared using the absolute difference between 77 methods 1 and 2, and plotted using matplotlib 3.0. and "washout" were used as replicates. Genes were compared across WHIM samples using one-way 88 analysis of variance (ANOVA), and the FDR was calculated and set to a limit of 0.05 using the Benjamini-89
Hochberg method (RStudio 1.0.153). Data were graphed using ggplot. 90 91 Pathway analysis of PDX stroma 92
Differentially-regulated stromal gene lists from both PDX studies 2,3 as determined by FDR-corrected 93 ANOVA were combined for pathway analysis. Mouse genes were further filtered by removing plasma 4 94 and abundant erythrocyte proteins identified by proteomics 5 prior to downstream analysis. The web-95 based gene set analysis toolkit WebGestalt 6 was used for overrepresentation analysis of the stromal 96 proteins differentially regulated by PDX tumors in either dataset (2,2293 genes) versus those that were 97 not (671 genes) using the default parameters, Homo sapiens as the organism, redundant datasets, and 98 the affinity propagation option for redundancy reduction. 99 100
Genus-level peptidome diversity 101
Taxonomic representation and sequence diversity at the tryptic peptide level was calculated using a 102 modified version of ProteoClade's PCDB module. A tryptic digest of the complete Swiss-Prot and TrEMBL 103 sequences (release 2018_11) using ProteoClade's default parameters was performed, but rather than 104 assign peptides to organisms, non-compressed peptides were assigned directly to genera. Each peptide 105 in the resultant database was checked for genus specificity, and the number of unique and shared 106 peptides for each genus was tallied using custom scripts. Data for the number of unique peptides and 107 fraction shared between genera were plotted using matplotlib. 108 109 Oral microbiome de novo search 110 Raw spectra from the Grassl et al. study 7 were retrieved from ProteomeXchange under ID PXD003028. A 111 de novo search was performed using PEAKS Studio X (10) with the following parameters: the parent 112 mass error tolerance was set to 10 ppm, the fragment mass error tolerance was set to 0.05 Da, the 113 enzyme was set to trypsin, and MS2 fragmentation was set to higher energy collision-induced 114 dissociation (HCD). Cysteine carbamidomethylation was set as a fixed modification and methionine 115 oxidation was set as a variable modification. ProteoClade was used to make a PCDB of all 140.2 million 116 Swiss-Prot and TrEMBL (release 2018_11) sequences for annotation using its default parameters as 117 described in the implementation section. ProteoClade downloads and concatenates reference FASTA sequence databases and builds a ProteoClade database for fast taxon-specific protein quantitation. b) Comparison between taxon-specific and taxon-shared data processing approaches for a PDX data set. The theoretical fraction of shared peptides for each proteome (grey) correlates with the observed quantitative difference between the approaches. A baseline difference between these two analytic approaches was present due to how the assumptions made when assigning peptides to genes affected data normalization. c) A significant portion of the murine stromal proteome is differentially regulated by tumors. 3 biological replicates 'Rep' per tumor, indicated with circles. d) Pathway enrichment analysis of differentially regulated stromal proteins indicates an enrichment in proteins involved in cellular adhesion and the immune response. The schematic for ProteoClade's de novo pipeline supports the entire UniProt database and the conversion of peptide-spectral candidates to taxon-specific peptides. b) A characterization of the entire UniProt peptidome reveals the overrepresentation in the number of peptides contributed by bacterial genera (left), and the significant peptide diversity of microorganisms present in the repository (right). c) 39 bacterial genera from the Human Oral Microbiome Database were identified by the de novo search in addition to human. DB-Constraned: ProteoClade enhances de novo searches by providing the ability to constrain sequence candidates to a database for biological plausibility. "Reverse": ProteoClade controls the false discovery rate by generating a reversed sequence database. d) Comparing the forward and reverse UniProt databases resulted in human and 14 oral bacterial genera being identified by the de novo approach. Additional organisms were annotated but these annotations lacked statistical confidence. 
